Xact Kapitalforvaltning’s NeoGenomics NEO Stock Holding History

Xact Kapitalforvaltning’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$422K	Hold	15,300	–	–	0.01%	841
2019 Q4	$448K	Hold	15,300	–	–	0.01%	1030
2019 Q3	$293K	Hold	15,300	–	–	0.01%	1211
2019 Q2	$336K	Hold	15,300	–	–	0.01%	1155
2019 Q1	$313K	Buy	+15,300	New	+$266K	0.01%	1196

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Xact Kapitalforvaltning's NEO Position: Q1 2020 in Review

Xact Kapitalforvaltning held its NeoGenomics (NEO) position steady in Q1 2020 at 15,300 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #841.

Xact Kapitalforvaltning first reported a position in NEO in Q1 2019 and has held it in 5 quarters since. The position peaked at $448K in Q4 2019. 272 funds tracked by Wall St. Rank hold NEO as of Q1 2020.

Xact Kapitalforvaltning held 15,300 shares of NeoGenomics worth $422K as of Q1 2020.
Xact Kapitalforvaltning left its NeoGenomics share count unchanged in Q1 2020.
NeoGenomics made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #841 holding.
Xact Kapitalforvaltning first reported a position in NeoGenomics in Q1 2019 and has held it in 5 quarters since.
Xact Kapitalforvaltning's NeoGenomics position peaked at $448K in Q4 2019.
272 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.